3 unknown. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Huihan Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial rhTPO, Decitabine - Acute Myeloid Leukemia | Phase 3 | Unknown | Huihan Wang | 130 | 2022-01-21 | 2022-05-19 |
| Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study rhTPO - Acute Myeloid Leukemia | Not applicable | Unknown | Huihan Wang | 130 | 2022-01-21 | 2022-02-28 |
| D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients rhTPO - Acute Myeloid Leukemia | Not applicable | Unknown | Huihan Wang | 20 | 2019-11-01 | 2019-11-19 |
Aclarubicin (3) · Cytarabine (3) · Decitabine (3) · Granulocyte Colony-Stimulating Factor (3)
China (3)